We are live on
!
Find out more
Stifel Financial Portfolio holdings
AUM
$109B
1-Year Est. Return
21.36%
This Fund
S&P 500
This Quarter
Est. Return
+2.82%
1 Year Est. Return
+21.36%
3 Year Est. Return
+66.37%
5 Year Est. Return
+85.41%
10 Year Est. Return
+302.98%
AUM
$111B
AUM Growth
+$1.64B
(+1.5%)
Cap. Flow
-$76.5M
Cap. Flow
% of AUM
-0.07%
Top 10 Holdings %
Top 10 Hldgs %
17.73%
Holding
3,740
New
207
Increased
1,675
Reduced
1,597
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$276M |
| 2 |
Motorola Solutions
MSI
|
+$242M |
| 3 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$100M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$98.4M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$95.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$376M |
| 2 |
Clorox
CLX
|
+$258M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$79.6M |
| 4 |
Walmart Inc
WMT
|
+$72.9M |
| 5 |
NVIDIA
NVDA
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.25% |
| 2 | Financials | 9.51% |
| 3 | Industrials | 9.17% |
| 4 | Healthcare | 7.84% |
| 5 | Consumer Discretionary | 6.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Recursion Pharmaceuticals
RXRX
$1.69B
| $2.41M | ﹤0.01% |
590,148
+147,353
| +33% | +$730K |
|
1802
Ashland
ASH
$3.29B
| $2.41M | ﹤0.01% |
41,126
-1,801
| -4% | -$95.2K |
|
1803
Noble Corp
NE
$6.45B
| $2.41M | ﹤0.01% |
85,354
+1,394
| +2% | +$41.2K |
|
1804
Nuveen Core Plus Impact Fund
NPCT
$281M
| $2.4M | ﹤0.01% |
236,172
+24,241
| +11% | +$256K |
|
1805
Millicom
TIGO
$15.8B
| $2.4M | ﹤0.01% |
43,331
+6,223
| +17% | +$313K |
|
1806
iShares iBonds Dec 2032 Term Treasury ETF
IBTM
$558M
| $2.39M | ﹤0.01% |
103,777
+3,833
| +4% | +$88.9K |
|
1807
Invesco BuyBack Achievers ETF
PKW
$1.74B
| $2.39M | ﹤0.01% |
17,821
-245
| -1% | -$32.3K |
|
1808
Petrobras Class A
PBR.A
$109B
| $2.39M | ﹤0.01% |
212,394
+30,064
| +16% | +$347K |
|
1809
Aquestive Therapeutics
AQST
$476M
| $2.39M | ﹤0.01% |
369,728
+3,300
| +0.9% | +$20.6K |
|
1810
Pacer Data and Digital Revolution ETF
TRFK
$967M
| $2.38M | ﹤0.01% |
37,212
+31,891
| +599% | +$2.17M |
|
1811
First Trust Exchange-Traded Fund VI First Trust Hedged BuyWrite Income ETF
FTQI
$914M
| $2.38M | ﹤0.01% |
114,259
+8,692
| +8% | +$181K |
|
1812
VictoryShares Small Cap Free Cash Flow ETF
SFLO
$698M
| $2.38M | ﹤0.01% |
80,668
+5,950
| +8% | +$173K |
|
1813
STAAR Surgical
STAA
$1.21B
| $2.37M | ﹤0.01% |
+102,835
| New | +$2.65M |
|
1814
Goldman Sachs Access Ultra Short Bond ETF
GSST
$1.58B
| $2.37M | ﹤0.01% |
47,021
-2,306
| -5% | -$117K |
|
1815
Amneal Pharmaceuticals
AMRX
$6.02B
| $2.37M | ﹤0.01% |
188,332
-1,852
| -1% | -$21.2K |
|
1816
BioMarin Pharmaceuticals
BMRN
$11.6B
| $2.37M | ﹤0.01% |
39,929
+7,476
| +23% | +$407K |
|
1817
Alexandria Real Estate Equities
ARE
$9.24B
| $2.37M | ﹤0.01% |
48,446
-264,994
| -85% | -$15.6M |
|
1818
Eaton Vance Ultra-Short Income ETF
EVSB
$244M
| $2.37M | ﹤0.01% |
46,565
+7,771
| +20% | +$396K |
|
|
IIF
1819
Morgan Stanley India Investment Fund
IIF
$219M
| $2.36M | ﹤0.01% |
94,630
+7,094
| +8% | +$189K |
|
1820
Life Time Group Holdings
LTH
$9.87B
| $2.36M | ﹤0.01% |
88,811
+3,714
| +4% | +$96.7K |
|
1821
Werner Enterprises
WERN
$2.23B
| $2.36M | ﹤0.01% |
78,563
+846
| +1% | +$23.2K |
|
1822
Utz Brands
UTZ
$1.25B
| $2.36M | ﹤0.01% |
227,002
+7,557
| +3% | +$81.5K |
|
1823
iShares Global Infrastructure ETF
IGF
$10.9B
| $2.35M | ﹤0.01% |
38,329
+4,228
| +12% | +$261K |
|
1824
State Street SPDR S&P Telecom ETF
XTL
$583M
| $2.35M | ﹤0.01% |
15,349
+364
| +2% | +$54K |
|
1825
Badger Meter
BMI
$3.97B
| $2.35M | ﹤0.01% |
13,466
+599
| +5% | +$108K |
|
Similar funds
Stifel Financial's Q4 2025 Portfolio in Review
As of Q4 2025, Stifel Financial held 3,740 positions worth $111B, up 1.5% from $110B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Stifel Financial's Q4 2025 filing shows 207 new, 1,675 increased, 1,597 reduced and 175 closed positions. Its largest new stake was Akre Focus ETF: 233,094 shares worth $15.3M. The largest sale was Oracle, an estimated $376M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Industrials.
- Stifel Financial's largest Q4 2025 buy was Akre Focus ETF: 233,094 shares worth $15.3M.
- Stifel Financial added most to Abbott in Q4 2025, an estimated $276M increase.
- Stifel Financial's biggest Q4 2025 reduction was Oracle, cutting an estimated $376M.
- Stifel Financial fully exited Invesco BulletShares 2025 Corporate Bond ETF in Q4 2025, selling an estimated $12.1M.
- Stifel Financial's ten largest holdings make up 18% of its $111B portfolio in Q4 2025.
- Stifel Financial opened 207 new positions and closed 175 in Q4 2025.
- Stifel Financial's portfolio value rose 1.5% quarter-over-quarter to $111B.
Based on Stifel Financial's 13F filing for Q4 2025, filed 13 Feb 2026.